Chase Sun Pharmaceuticals released its performance for the first three quarters, with a net profit attributable to the parent company of 80.7629 million yuan, a decrease of 52.03%
Chase Sun Pharmaceuticals released its Q3 2025 report, with a revenue of 4.149 billion yuan for the first three quarters, a year-on-year decrease of 6.59%. The net profit attributable to the parent company was 80.7629 million yuan, a year-on-year decline of 52.03%. The net profit after deducting non-recurring gains and losses was 88.7048 million yuan, a year-on-year decrease of 43.81%. The basic earnings per share were 0.03 yuan
According to the Zhitong Finance APP, Chase Sun (300026.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 4.149 billion yuan, a year-on-year decrease of 6.59%. The net profit attributable to shareholders of the listed company was 80.7629 million yuan, a year-on-year decrease of 52.03%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 88.7048 million yuan, a year-on-year decrease of 43.81%. The basic earnings per share were 0.03 yuan
